Enhancing "Patient-Reported Outcomes" through Wearable Technology and the Rise of "Home-Based" Clinical Assessments within the Duchenne Muscular Dystrophy Treatment Sector for 2026
In early 2026, the way we measure "Success" in Duchenne treatment is moving out of the hospital and into the home. Traditional tests like the "6-Minute Walk Test" (6MWT) are being supplemented—and in some cases replaced—by "Wearable Stride Monitors." These devices, worn on the ankle or wrist, provide a "Continuous Stream" of data on how a child moves in their natural environment...
0 Comments 0 Shares 230 Views 0 Reviews
Sponsored

Real Profits Start Here – Try Stockity Today!

Experience fast and simple online trading with Stockity. Learn, practice, and trade with real-time market tools designed for everyone — beginners to pros.